ID   CLC2I_MOUSE             Reviewed;         217 AA.
AC   Q9WVF9; Q1AFZ2; Q7TSP6; Q7TSP7; Q8BFR3; Q924B1;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   03-AUG-2022, entry version 142.
DE   RecName: Full=C-type lectin domain family 2 member I;
DE   AltName: Full=C-type lectin-related protein DCL1;
DE   AltName: Full=C-type lectin-related protein G;
DE            Short=Clr-g;
DE   AltName: Full=Lymphoid-derived C-type lectin-1;
DE            Short=LCL-1;
DE   AltName: Full=Osteoclast inhibitory lectin-related protein 2;
DE            Short=Ocil-related protein 2;
GN   Name=Clec2i; Synonyms=Clrg, Dcl1, Ocilrp2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J; TISSUE=Natural killer cell;
RX   PubMed=11398965; DOI=10.1007/s002510100319;
RA   Plougastel B., Dubbelde C., Yokoyama W.M.;
RT   "Cloning of Clr, a new family of lectin-like genes localized between mouse
RT   Nkrp1a and Cd69.";
RL   Immunogenetics 53:209-214(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), FUNCTION,
RP   INDUCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=129/Sv, and C57BL/6J;
RX   PubMed=12374791; DOI=10.1074/jbc.m209059200;
RA   Zhou H., Kartsogiannis V., Quinn J.M.W., Ly C., Gange C., Elliott J.,
RA   Ng K.W., Gillespie M.T.;
RT   "Osteoclast inhibitory lectin, a family of new osteoclast inhibitors.";
RL   J. Biol. Chem. 277:48808-48815(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4), FUNCTION, SUBCELLULAR
RP   LOCATION, INDUCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J; TISSUE=Spleen;
RX   PubMed=15963483; DOI=10.1016/j.cellimm.2005.04.021;
RA   Tian W., Nunez R., Cheng S., Ding Y., Tumang J., Lyddane C., Roman C.,
RA   Liou H.-C.;
RT   "C-type lectin OCILRP2/Clr-g and its ligand NKRP1f costimulate T cell
RT   proliferation and IL-2 production.";
RL   Cell. Immunol. 234:39-53(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=BALB/cJ; TISSUE=Dendritic cell;
RA   Gorski K.S., Huang X., Pardoll D.M., Tsuchiya H.;
RT   "A novel c-type lectin (DCL1) expressed in bone marrow derived dendritic
RT   cells.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 78-171.
RC   STRAIN=BALB/cByJ;
RX   PubMed=16751398; DOI=10.4049/jimmunol.176.12.7511;
RA   Carlyle J.R., Mesci A., Ljutic B., Belanger S., Tai L.-H., Rousselle E.,
RA   Troke A.D., Proteau M.-F., Makrigiannis A.P.;
RT   "Molecular and genetic basis for strain-dependent NK1.1 alloreactivity of
RT   mouse NK cells.";
RL   J. Immunol. 176:7511-7524(2006).
CC   -!- FUNCTION: Inhibits osteoclast formation. Receptor for KLRB1F. Enhances
CC       T-cell activation. Plays a role in splenocyte activation, T-cell
CC       responses and IL-2 production. {ECO:0000269|PubMed:12374791,
CC       ECO:0000269|PubMed:15963483}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type II
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9WVF9-1; Sequence=Displayed;
CC       Name=2; Synonyms=Lymphoid-derived C-type lectin-1b, LCL-1b;
CC         IsoId=Q9WVF9-2; Sequence=VSP_030532;
CC       Name=3; Synonyms=Lymphoid-derived C-type lectin-1a, LCL-1a;
CC         IsoId=Q9WVF9-3; Sequence=VSP_030531, VSP_030532;
CC       Name=4; Synonyms=Lymphoid-derived C-type lectin-1c, LCL-1c;
CC         IsoId=Q9WVF9-4; Sequence=VSP_030530;
CC   -!- TISSUE SPECIFICITY: Detected in osteoblasts, growth plate chondrocytes
CC       and skeletal muscle overlying the bone (at protein level). Detected in
CC       spleen, B-cells, dendritic cells, thymus, and in IL2-activated natural
CC       killer cells. {ECO:0000269|PubMed:11398965,
CC       ECO:0000269|PubMed:12374791, ECO:0000269|PubMed:15963483}.
CC   -!- INDUCTION: Up-regulated in CD4(+) T-cells upon stimulation with CD3-
CC       ligands. Up-regulated in cultured calvarial osteoblasts by 1,25-
CC       dihydroxyvitamin D3. Constitutively expressed in cultured bone marrow
CC       cells during osteoclast formation. {ECO:0000269|PubMed:12374791,
CC       ECO:0000269|PubMed:15963483}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK70359.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF350411; AAK70359.1; ALT_INIT; mRNA.
DR   EMBL; AY137343; AAN15951.1; -; Genomic_DNA.
DR   EMBL; AY137343; AAN15952.1; -; Genomic_DNA.
DR   EMBL; AY137344; AAN15953.1; -; mRNA.
DR   EMBL; AY137345; AAN15954.1; -; mRNA.
DR   EMBL; AY256574; AAP32744.1; -; mRNA.
DR   EMBL; AY256575; AAP32745.1; -; mRNA.
DR   EMBL; AY256576; AAP32746.1; -; mRNA.
DR   EMBL; AF121352; AAD22055.1; -; mRNA.
DR   EMBL; DQ143112; ABA43362.1; -; Genomic_DNA.
DR   CCDS; CCDS51920.1; -. [Q9WVF9-1]
DR   CCDS; CCDS71844.1; -. [Q9WVF9-2]
DR   CCDS; CCDS85166.1; -. [Q9WVF9-4]
DR   RefSeq; NP_001276635.1; NM_001289706.1.
DR   RefSeq; NP_001276636.1; NM_001289707.1. [Q9WVF9-2]
DR   RefSeq; NP_001276637.1; NM_001289708.1. [Q9WVF9-4]
DR   RefSeq; NP_064653.1; NM_020257.2. [Q9WVF9-1]
DR   PDB; 3RS1; X-ray; 1.94 A; A/B=85-206.
DR   PDBsum; 3RS1; -.
DR   AlphaFoldDB; Q9WVF9; -.
DR   SMR; Q9WVF9; -.
DR   BioGRID; 220229; 1.
DR   STRING; 10090.ENSMUSP00000123804; -.
DR   GlyGen; Q9WVF9; 1 site.
DR   iPTMnet; Q9WVF9; -.
DR   PhosphoSitePlus; Q9WVF9; -.
DR   PaxDb; Q9WVF9; -.
DR   PRIDE; Q9WVF9; -.
DR   ProteomicsDB; 283277; -. [Q9WVF9-1]
DR   ProteomicsDB; 283278; -. [Q9WVF9-2]
DR   ProteomicsDB; 283279; -. [Q9WVF9-3]
DR   ProteomicsDB; 283280; -. [Q9WVF9-4]
DR   DNASU; 93675; -.
DR   Ensembl; ENSMUST00000032519; ENSMUSP00000032519; ENSMUSG00000030365. [Q9WVF9-1]
DR   Ensembl; ENSMUST00000159866; ENSMUSP00000123804; ENSMUSG00000030365. [Q9WVF9-2]
DR   Ensembl; ENSMUST00000160867; ENSMUSP00000145115; ENSMUSG00000030365. [Q9WVF9-4]
DR   GeneID; 93675; -.
DR   KEGG; mmu:93675; -.
DR   UCSC; uc009eeu.2; mouse. [Q9WVF9-1]
DR   CTD; 93675; -.
DR   MGI; MGI:2136650; Clec2i.
DR   VEuPathDB; HostDB:ENSMUSG00000030365; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00940000155319; -.
DR   HOGENOM; CLU_049894_8_1_1; -.
DR   InParanoid; Q9WVF9; -.
DR   OMA; NISSCCA; -.
DR   OrthoDB; 1140637at2759; -.
DR   TreeFam; TF351467; -.
DR   BioGRID-ORCS; 93675; 1 hit in 71 CRISPR screens.
DR   ChiTaRS; Clec2i; mouse.
DR   PRO; PR:Q9WVF9; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   RNAct; Q9WVF9; protein.
DR   Bgee; ENSMUSG00000030365; Expressed in thymus and 36 other tissues.
DR   ExpressionAtlas; Q9WVF9; baseline and differential.
DR   Genevisible; Q9WVF9; MM.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0030246; F:carbohydrate binding; ISS:MGI.
DR   GO; GO:0046703; F:natural killer cell lectin-like receptor binding; IDA:MGI.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; ISS:MGI.
DR   GO; GO:0001765; P:membrane raft assembly; NAS:BHF-UCL.
DR   GO; GO:0045671; P:negative regulation of osteoclast differentiation; NAS:BHF-UCL.
DR   GO; GO:2000522; P:positive regulation of immunological synapse formation; NAS:BHF-UCL.
DR   GO; GO:0043113; P:receptor clustering; IMP:MGI.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IMP:MGI.
DR   GO; GO:0032663; P:regulation of interleukin-2 production; IMP:MGI.
DR   GO; GO:0042129; P:regulation of T cell proliferation; IMP:MGI.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IMP:MGI.
DR   CDD; cd03593; CLECT_NK_receptors_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR033992; NKR-like_CTLD.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Disulfide bond;
KW   Glycoprotein; Lectin; Membrane; Receptor; Reference proteome;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN           1..217
FT                   /note="C-type lectin domain family 2 member I"
FT                   /id="PRO_0000315291"
FT   TOPO_DOM        1..53
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        54..74
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        75..217
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          99..203
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   CARBOHYD        112
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        92..103
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DISULFID        120..202
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   VAR_SEQ         1..61
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15963483"
FT                   /id="VSP_030530"
FT   VAR_SEQ         1..15
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15963483"
FT                   /id="VSP_030531"
FT   VAR_SEQ         35
FT                   /note="G -> GVQCC (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12374791,
FT                   ECO:0000303|PubMed:15963483"
FT                   /id="VSP_030532"
FT   STRAND          87..91
FT                   /evidence="ECO:0007829|PDB:3RS1"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:3RS1"
FT   STRAND          102..106
FT                   /evidence="ECO:0007829|PDB:3RS1"
FT   HELIX           113..122
FT                   /evidence="ECO:0007829|PDB:3RS1"
FT   HELIX           133..142
FT                   /evidence="ECO:0007829|PDB:3RS1"
FT   TURN            143..145
FT                   /evidence="ECO:0007829|PDB:3RS1"
FT   STRAND          148..153
FT                   /evidence="ECO:0007829|PDB:3RS1"
FT   STRAND          180..185
FT                   /evidence="ECO:0007829|PDB:3RS1"
FT   STRAND          188..192
FT                   /evidence="ECO:0007829|PDB:3RS1"
FT   STRAND          200..205
FT                   /evidence="ECO:0007829|PDB:3RS1"
SQ   SEQUENCE   217 AA;  24671 MW;  28D497A39F05DCD8 CRC64;
     MPDCLETGEK LFVHNMNAQC VQKPEEGNGP LGTGGKIVQG KCFRIISTVS PVKLYCCYGV
     IMVLTVAVIA LSVALSTKKT EQIIINKTYA ACSKNWTGVG NKCFYFSGYP RNWTFAQAFC
     MAQEAQLARF DNEEELIFLK RFKGDFDCWI GLHRESSEHP WKWTNNTEYN NMNPILGVGR
     YAYLSSDRIS SSRSYINRMW ICSKLNNYNL HCQTPPV
//
